颅内桥小脑角区恶性黑色素瘤1例并文献复习
Malignant Melanoma in Cerebellopontine Angle: A Case Report and Literature Review
DOI: 10.12677/ACM.2022.127982, PDF,   
作者: 潘灵峰:青岛大学,山东 青岛;宫安静*:青岛大学附属医院神经外科,山东 青岛
关键词: 恶性黑色素瘤桥小脑角区原发性Malignant Melanoma Cerebellopontine Angle Primary
摘要: 原发性颅内黑色素瘤是一种极为罕见的脑部病变,约占所有黑色素瘤病例的1%。继发性颅内恶性黑色素瘤大多原发于体表皮肤恶性黑色素瘤,且颅内继发恶性黑色素瘤一般位于大脑实质内。颅内黑色素瘤恶性程度高,生长速度快,浸润性生长范围广泛,手术不易彻底切除,术后易复发,预后极差,目前能有效控制颅内黑色素瘤的治疗手段有限。发生于颅内桥小脑角区的恶性黑色素瘤较少报道,本文报道一例桥小脑角区恶性黑色素瘤,血供丰富,呈浸润性生长,与周围组织粘连紧密,手术切除复杂,希望为颅内桥小脑角区恶性黑色素瘤提供更多治疗参考。
Abstract: Primary intracranial melanoma is an extremely rare brain lesion that accounts for about 1% of all melanoma cases. Secondary intracranial malignant melanoma mostly originates from superficial cutaneous malignant melanoma, and the secondary intracranial malignant melanoma is usually lo-cated in the brain parenchyma. Intracranial melanoma has a high degree of malignancy, fast growth rate, and a wide range of invasive growth. It is not easy to be completely resected by surgery, and postoperative recurrence is easy, with a poor prognosis. Currently, there are limited therapeutic methods that can effectively control intracranial melanoma. Malignant melanoma occurring in the intracranial pontine Angle is rarely reported. This paper reports a case of malignant melanoma in cerebellopontine angle region, which has abundant blood supply, infiltrative growth, close adhesion with surrounding tissues, and complex surgical resection. It is hoped to provide more treatment references for malignant melanoma in cerebellopontine angle region.
文章引用:潘灵峰, 宫安静. 颅内桥小脑角区恶性黑色素瘤1例并文献复习[J]. 临床医学进展, 2022, 12(7): 6812-6818. https://doi.org/10.12677/ACM.2022.127982

参考文献

[1] Sarmast, A.H., Mujtaba, B., Bhat, A.R., et al. (2018) A Unique Case of Primary Intracranial Melanoma. Asian Journal of Neurosurgery, 13, 168-171. [Google Scholar] [CrossRef] [PubMed]
[2] Balakrishnan, R., Porag, R., Asif, D.S., et al. (2015) Primary Intracranial Melanoma with Early Leptomeningeal Spread: A Case Report and Treatment Op-tions Available. Case Reports in Oncological Medicine, 2015, Article ID: 293802. [Google Scholar] [CrossRef] [PubMed]
[3] Offiah, C.J. and Laitt, R.D. (2006) Case Report: Intracranial Meningeal Melanocytoma: A Cause of High Signal on T1- and Low Signal on T2-Weighted MRI. Clinical Radiology, 61, 294-298. [Google Scholar] [CrossRef] [PubMed]
[4] Suranagi, V.V., Maste, P. and Malur, P.R. (2015) Primary Intra-cranial Malignant Melanoma: A Rare Case with Review of Literature. Asian Journal of Neurosurgery, 10, 39-41. [Google Scholar] [CrossRef] [PubMed]
[5] Escott, E.J. (2001) A Variety of Appearances of Malignant Mela-noma in the Head: A Review. Radiographics, 21, 625-639. [Google Scholar] [CrossRef] [PubMed]
[6] 罗毅男, 葛鹏飞, 付双林, 等. 颅内黑色素瘤的诊断与治疗[J]. 中华神经外科杂志, 2003, 19(2): 138-140.
[7] 王爱华, 李庆红. 颅内黑色素瘤的影像诊断[J]. 医学影像学杂志, 2007, 17(9): 935, 994.
[8] Shah, I., Imran, M., Akram, R., et al. (2013) Primary Intracranial Malig-nant Melanoma. Journal of College of Physicians and Surgeons Pakistan, 23, 157-159.
[9] Ma, J., Zhang, Z., Li, S., et al. (2015) Intracranial Amelanotic Melanoma: A Case Report with Literature Review. World Journal of Surgical Oncol-ogy, 13, 182. [Google Scholar] [CrossRef] [PubMed]
[10] Park, J.H. and Hong, Y.K. (2014) Primary Malig-nant Melanoma in the Pineal Region. Journal of Korean Neurosurgical Society, 56, 504-508. [Google Scholar] [CrossRef] [PubMed]
[11] 赵美华, 窦娅芳, 梁宗辉, 等. 中枢神经系统黑色素细胞肿瘤的影像学诊断[J]. 中国医学计算机成像杂志, 2012, 18(6): 477-480. [Google Scholar] [CrossRef
[12] Garbe, C., Eigentler, T.K., Keilholz, U., et al. (2011) Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects. Oncologist, 16, 5-24. [Google Scholar] [CrossRef] [PubMed]
[13] Balch, C.M., Gershenwald, J.E., Soong, S.J., et al. (2009) Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of Clinical Oncology, 27, 6199-6206. [Google Scholar] [CrossRef
[14] Margolin, K., Atkins, B., Thompson, A., et al. (2002) Te-mozolomide and Whole Brain Irradiation in Melanoma Metastatic to the Brain: A Phase II Trial of the Cytokine Working Group. Journal of Cancer Research and Clinical Oncology, 128, 214-218. [Google Scholar] [CrossRef] [PubMed]